ArticleDermatology and therapy2023

InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study.

Federico Diotallevi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.